shCD44-2 pRRL Citations (4)

Originally described in: Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.
Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, McAllister SS, Jacks T, Weinberg RA Cell. 2008 Jul 11. 134(1):62-73. PubMed Journal

---

Articles Citing shCD44-2 pRRL

Articles
CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness and response to therapy. Zhao S, Chen C, Chang KW, Karnad A, Jagirdar J, Kumar AP, Freeman JW. Clin Cancer Res. 2016 Jun 7. pii: clincanres.3115.2015. PubMed
Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. Weitzenfeld P, Meshel T, Ben-Baruch A. Oncotarget. 2016 Dec 6;7(49):81123-81143. doi: 10.18632/oncotarget.13213. PubMed
Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma. Xiao W, Wang S, Zhang R, Sohrabi A, Yu Q, Liu S, Ehsanipour A, Liang J, Bierman RD, Nathanson DA, Seidlits SK. Matrix Biol. 2019 Apr 24. pii: S0945-053X(19)30022-8. doi: 10.1016/j.matbio.2019.04.003. PubMed
Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43. Spertini C, Baisse B, Bellone M, Gikic M, Smirnova T, Spertini O. Cancers (Basel). 2019 Aug 27;11(9). pii: cancers11091253. doi: 10.3390/cancers11091253. PubMed

If you have published an article using this material, please email us at to have your article added to this page.